Developing a Risk Based Approach to Validation for Life Sciences

25
Developing a Risk Based Approach to Validation for Life Sciences Presented by Bill Gargano March 20, 2012

description

Developing a Risk Based Approach to Validation for Life Sciences. Presented by Bill Gargano March 20, 2012. Topics. Core Definitions Categorizing risks and their respective plans Reduce Testing in a Risk Based Environment Developing a “How To ” Guide Developing documentation standards - PowerPoint PPT Presentation

Transcript of Developing a Risk Based Approach to Validation for Life Sciences

Page 1: Developing a Risk Based Approach to Validation for Life Sciences

Developing a Risk Based Approach to Validation for Life Sciences

Presented by Bill GarganoMarch 20, 2012

Page 2: Developing a Risk Based Approach to Validation for Life Sciences

Core Definitions Categorizing risks and their respective plans Reduce Testing in a Risk Based Environment Developing a “How To” Guide Developing documentation standards Differentiating tasks that will reduce time and

effort Impacting strategies for maintenance Optimizing the Validation Plan

Topics

Page 3: Developing a Risk Based Approach to Validation for Life Sciences

As far back as August 2002 the Food and Drug Administration (FDA) urged an industry change creating a Quality Systems Framework.

• Encourage implementation of risk-based approaches that focus both industry and Agency attention on critical areas

• Ensure that regulatory review, compliance, and inspection policies are based on state-of-the-art pharmaceutical science

When and Why?

Page 4: Developing a Risk Based Approach to Validation for Life Sciences

• Hazard – Potential source of harm; condition that can cause harm or lead to a mishap

• Harm, mishap – Injury or death to persons, damage to property or the environment, or damage to or loss of data

• Risk – Combination of the probability, severity, and the likelihood of that harm

• Hazard Analysis - A technique used to identify conceivable failures affecting system performance, human safety, or other required characteristics.

• Risk Analysis - Systematic use of available information to identify hazards and to estimate the risk

• Risk Assessment - An overall process comprising a risk analysis and a risk evaluation

• Risk Evaluation - Judgment, on the basis of risk analysis, of whether a risk which is acceptable has been achieved in a given context based on the current values of society

• Risk Management – Bringing all of the above together in one process

Core Definitions

Page 5: Developing a Risk Based Approach to Validation for Life Sciences

RISK MANAGEMENT Ask questions – Apply the process

Risk Analysis What COULD go wrong?IDENTIFY what could go wrong

Risk Evaluation How bad is it?Estimate the:SEVERITY – LIKELIHOOD - DETECTABILITY

Risk Control Can the situation be improved?Take preventive or corrective actions

Post Production Info What have we LEARNED from this?Check and review actual results!

Risk Management

Page 6: Developing a Risk Based Approach to Validation for Life Sciences

• The risk based approach tailors the level of validation activity to the increased complexity or increased impact of the system. Im

pact

ComplexityActi

vities

High

Low High

The Risk Based Approach

Page 7: Developing a Risk Based Approach to Validation for Life Sciences

Activities Involved in Risk

Page 8: Developing a Risk Based Approach to Validation for Life Sciences

• Test the areas pose the greatest risk to product quality and patient safety

• Overall validation costs are reduced and efficiency is increased

• Identify all relevant systems that require validation

• Determine how to validate, and the extent of validation required, for the systems that have been identified

Justification

Page 9: Developing a Risk Based Approach to Validation for Life Sciences

Identifying, evaluating, controlling, and mitigating risk may allow for:– Shorter development cycle– More robust product/process– Fewer complaints, returns, and warranty claims– Fewer recalls and less subsequent agency

attention– Continuous improvement of Risk Assessment

techniques and practices

Biz Considerations

Page 10: Developing a Risk Based Approach to Validation for Life Sciences

Total Cost of Ownership using a Risk Based Methodology is lowered.

– Better predictability for Time to Market– ROI based Risk strategies result in almost 99% defect free

validated applications– Overall knowledge domain of staff increased by utilizing

specialized skill sets and testing methods– Better software quality – reduction in help-desk calls– Consolidation of the enterprise testing infrastructure– A reduction of up to 20% in the Cost of Quality, as defects are

identified and corrected earlier in the process

TOC

Page 12: Developing a Risk Based Approach to Validation for Life Sciences

• FTA – Fault Tree Analysis• FMEA – Failure Mode and Effects Analysis• FMECA - Failure Mode and Effects Criticality

Analysis• NIST Special Publication 800-30 –

Government standard for use with IT systems (National Institute of Standards and Technology)

• MIL-STD-882D – Used by DoD• ISO – Standards• HACCP – Hazard Analysis and Critical Control

Point -Standard for food products• GAMP 5 – European voluntary standard, pharma

automation

Existing Models

Page 13: Developing a Risk Based Approach to Validation for Life Sciences

How Activities Correlate to Risk

Release Management

Design

Project Coordination

Vendor Management

Traceability Business Impact Analysis

TrainingSupport

Configuration Management

Phase Review

Development Standards

Failure Analysis

Data Management

Code Review

Safety Impact Activities

Compliance Impact Activities

Validation Reporting

Change Management

Validation Planning

TestingRequirements Management

Core Validation Activities

Incr

easi

ng L

evel

s of

Impa

ct

Page 15: Developing a Risk Based Approach to Validation for Life Sciences

• Assign Risk Priority Number (RPN)• Taking into consideration the severity of the

risk, the likelihood of the risk occurring, and the detectability of that risk as it is occurring, a risk priority number can be calculated using the formula:

Severity x Likelihood x Detectability = RPN

• RPN also referred to as a Risk Index (RI)

Risk Priority Number

Page 16: Developing a Risk Based Approach to Validation for Life Sciences

Ranking Rating Criteria

1 Low Minor negative impact, no long-

term detrimental impact2 Moderate Moderate negative

impact, someshort-to medium-term

detrimentalimpact

3 High Very significant negative impact,

significant long-term effects and

potentially catastrophic short-term

impacts

FMEA Rankings

Page 17: Developing a Risk Based Approach to Validation for Life Sciences

Assign Risk Classification• Having assigned

the likelihood and business impact, use a matrix to classify the risk• Level 1 is highest• Level 3 is lowest

Risk Classification

Page 18: Developing a Risk Based Approach to Validation for Life Sciences

Determine Appropriate Measures for Risk Mitigation• By combining Risk

Classification with Probability of Detection, prioritize based upon those areas of greatest vulnerability

• Modify process or system elements

• Modify project strategy• Modify validation

approach• Eliminate risk

Risk Mitigation

Page 19: Developing a Risk Based Approach to Validation for Life Sciences

SYSTEM GAMP

HIGH RISK ON SITE VENDOR AUDIT

MEDIUM RISK ASSESSMENT VIA MAIL(Checklists)

LOW RISK DOCUMENTATION FROM VENDOR, REPUTATION

Incr

easi

ng C

ontr

ols

Incr

easi

ng C

osts

Example: Vendor Assessment

Page 20: Developing a Risk Based Approach to Validation for Life Sciences

COMPUTER SYSTEM DOCUMENTATION

HIGH RISK All including SAD, SID, IQ, OQ, PQ, QA Checklist, and more

MEDIUM RISK Same as Low – Add IQ and OQ alone, Risk Assessment

LOW RISK VMP, URS/FRS, IQ/OQ, Single Summary ReportIn

crea

sing

Doc

umen

tatio

n

Incr

easi

ng C

osts

Example: CSV Validation

Page 21: Developing a Risk Based Approach to Validation for Life Sciences

Plan Testing Mapping

Page 22: Developing a Risk Based Approach to Validation for Life Sciences

• Assess current Risk Model :– Look at standards, validation procedures, previous RA,

governance• Establish NEW Risk Model:

– Work with client to pinpoint areas of highest concern (Mfg, Lab, Clinical)

– Begin with current RCM Framework and modify to client needs

• QA:– Need to gain acceptance from this group in a non-

threatening way– Typically set in their ways – culture change

• “We have a model already”:– Is everyone following that model?– What savings have you seen? In other words, is it

working?

Where to Start and Challenges

Page 25: Developing a Risk Based Approach to Validation for Life Sciences

THANK YOU FOR YOUR TIME!